EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Exploring the metabolic profile of A. baumannii for antimicrobial development using genome-scale modeling

Nantia Leonidou iD, Yufan Xia iD, Lea Friedrich iD, Monika S Schütz iD, Andreas Dräger iD

PLOS Pathogens · 2024

DOI: 10.1371/journal.ppat.1012528 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS Pathogens, 2024. Verfasst von Nantia Leonidou und 4 weiteren Autor:innen. Beteiligte Einrichtung: Computational Systems Biology of Infections and Antimicrobial-Resistant Pathogens, Institute for Bioinformatics and Medical Informatics (IBMI), Eberh…. Hauptthemen laut MEDLINE: Acinetobacter baumannii, Anti-Bacterial Agents. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 109 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Germany’s Excellence Strategy, Deutsche Forschungsgemeinschaft, Cluster of Excellence 'Controlling Microbes to Fight Infections'.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

With the emergence of multidrug-resistant bacteria, the World Health Organization published a catalog of microorganisms urgently needing new antibiotics, with the carbapenem-resistant Acinetobacter baumannii designated as “critical”. Such isolates, frequently detected in healthcare settings, pose a global pandemic threat. One way to facilitate a systemic view of bacterial metabolism and allow the development of new therapeutics is to apply constraint-based modeling. Here, we developed a versatile workflow to build high-quality and simulation-ready genome-scale metabolic models. We applied our workflow to create a metabolic model for A . baumannii and validated its predictive capabilities using experimental nutrient utilization and gene essentiality data. Our analysis showed that our model i ACB23LX could recapitulate cellular metabolic phenotypes observed during in vitro experiments, while positive biomass production rates were observed and experimentally validated in various growth media. We further defined a minimal set of compounds that increase A . baumannii ’s cellular biomass and identified putative essential genes with no human counterparts, offering new candidates for future antimicrobial development. Finally, we assembled and curated the first collection of metabolic reconstructions for distinct A . baumannii strains and analyzed their growth characteristics. The presented models are in a standardized and well-curated format, enhancing their usability for multi-strain network reconstruction.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Acinetobacter baumanniiAnti-Bacterial AgentsGenome, BacterialHumansAcinetobacter InfectionsMetabolomeDrug Resistance, Multiple, BacterialModels, BiologicalMicrobial Sensitivity Tests

Substanzen

Anti-Bacterial Agents

Autor:innen und Institutionen

  • Computational Systems Biology of Infections and Antimicrobial-Resistant Pathogens, Institute for Bioinformatics and Medical Informatics (IBMI), Eberhard Karl University of Tübingen, Tübingen, Germany.
  • Department of Computer Science, Eberhard Karl University of Tübingen, Tübingen, Germany.
  • Cluster of Excellence 'Controlling Microbes to Fight Infections', Eberhard Karl University of Tübingen, Tübingen, Germany.
  • German Center for Infection Research (DZIF), partner site Tübingen, Germany.
  • Quantitative Biology Center (QBiC), Eberhard Karl University of Tübingen, Tübingen, Germany.
  • Interfaculty Institute for Microbiology and Infection Medicine, Institute for Medical Microbiology and Hygiene, University Hospital Tübingen, Tübingen, Germany.

ORCID-Profile: Nantia Leonidou, Yufan Xia, Lea Friedrich, Monika S Schütz, Andreas Dräger

Förderung

  • Germany’s Excellence Strategy
  • Deutsche Forschungsgemeinschaft
  • Cluster of Excellence 'Controlling Microbes to Fight Infections'
  • Deutsches Zentrum für Infektionsforschung
  • Open Access Publishing Fund of the University of Tübingen

Zitieren

APA

Leonidou, N., Xia, Y., Friedrich, L., Schütz, M. S., & Dräger, A. (2024). Exploring the metabolic profile of A. baumannii for antimicrobial development using genome-scale modeling. PLOS Pathogens. https://doi.org/10.1371/journal.ppat.1012528

Vancouver

Leonidou N, Xia Y, Friedrich L, Schütz MS, Dräger A. Exploring the metabolic profile of A. baumannii for antimicrobial development using genome-scale modeling. PLOS Pathogens. 2024. doi:10.1371/journal.ppat.1012528

BibTeX
@article{Leonidou2024,
  author = {Leonidou, Nantia and Xia, Yufan and Friedrich, Lea and Schütz, Monika S and Dräger, Andreas},
  title = {Exploring the metabolic profile of A. baumannii for antimicrobial development using genome-scale modeling},
  journal = {PLOS Pathogens},
  year = {2024},
  doi = {10.1371/journal.ppat.1012528}
}
Kostenlos starten →